Insiders Pharmadrug Inc.

Equities

Market Closed - Canadian Securities Exchange Other stock markets 14:32:57 2024-06-28 EDT			5-day change	1st Jan Change
0.02 ^CAD	0.00%		0.00%	-63.64%

05-15	PharmaTher's Sairiyo Submits Clinical Trial Application in Australia For Phase 1 Study of Reformulated Cepharanthine	MT
05-02	PharmaDrug Announces Directorate Changes	CI

PharmaDrug Announces Directorate Changes	05-02	CI
PharmaDrug Inc Announces Board Changes	02-27	CI
PharmaDrug Inc. Announces Board Changes	23-09-06	CI
PharmaDrug Inc. Announces CEO Changes	23-09-06	CI
Pharmadrug Inc. Appoints David Posner to Its Advisory Committee and as Consultant	23-05-23	CI
PharmaDrug Inc. Announces Board Changes	22-01-13	CI
Pharmadrug Inc. Adds Cindy Hutnik to its Scientific and Clinical Advisory Board	21-12-13	CI
David Kideckel Joins the Board of Pharmadrug Inc	21-08-30	CI
Pharmadrug Inc. Promotes Dr. Paul Van Slyke to Chief Scientific Officer	21-05-13	CI
PharmaDrug Inc.'s Sariyo Therapeutics Inc. Appoints Yelena Y. Janjigian to Newly-Formed Scientific and Clinical Advisory Board	21-03-04	CI
PharmaDrug Appoints Steven A. Barker to Its Scientific Advisory Board for Psychedelic Pharmaceuticals	21-02-08	CI
Pharmadrug Inc. Announces Board Changes	20-06-19	CI
Pharmadrug Inc. Announces Appointment of Terry Booth as the Chairman of Its Advisory Board	20-06-02	CI
Pharmadrug Inc. Announces Board Changes	20-05-20	CI
Pharmadrug Inc. Announces Board Changes	19-11-19	CI
Aura Health Inc. has Changed its Name to Pharmadrug Inc	19-10-03	CI
Aura Health Inc. Appoints Al Quong to its Board of Directors and Chair of the Audit Committee	19-05-31	CI
Aura Health Inc. Announces the Resignation of Joel Freudman as Director	19-05-17	CI
Aura Health Inc. Announces Executive Changes	19-03-26	CI
Aura Health Inc. Appoints Howard Brass to the Role of Chief Operating Officer	18-11-19	CI

No results for this search